Some of the core issues of $GLOBALFOUNDRIES Inc.(GFS)$profitability in the past are largely due to its strong focus on manufacturing in US while starving its Asia plants from large orders. With new indications of refocus into Asia such as its $4 billion investment to its largest plant in Singapore (shorturl.at/ikBWX, tentatively operational in early 2023), its outlook seems promising. Every foundry that has plant in Taiwan and Singapore are profitable. Siltronics just announced investment into expansion in Singapore too.At right price, GFS is definitely a growth stockto invest for mid-term.
Countries with high vaccination rates and already started booster shots will likelihood continue with existing list of vaccines and will be low volume procurement just to satisfy those low % of people holding back from mRNA ones. Countries with low vaccination rates may explore alternative vaccine(s) if price is significantly cheaper. Overall, not expecting to sell in high volumes unlike mRNA ones where additional procurement to cater for booster shots already locked in or in the mist of it.
Novavax stock surged 14.2% in premarket trading<blockquote>Novavax股价在盘前交易中飙升14.2%</blockquote>
Corrections have not even really begin for most super overvalued stocks… Perhaps time will tell if it turns out a part of history where those younger investors who have never experienced the 2008/9, 2011/2, 2018 downturns will take a lesson or two.
Why September Shouldn't Make You Panic About the Stock Market<blockquote>为什么九月不会让你对股市感到恐慌</blockquote>
Yet on the flip side, there are decades old drugs which are getting ridiculously expensive. E.g. Panadol is now so expensive when it is not a new drug at all. Maybe the policy needs some kind of tweaking such as ‘applicable to drugs which have been release for >5 years, including any minor revisions to the same drug’.
White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称,白宫将宣布药品定价计划。医药股下跌。</blockquote>
A few lesser known/reported expansions are still ongoing and likelihood to complete around December. Once those capacity expansions complete, there will be more room for growth. Right now moving side-ways is largely due to capacity limitation (already max out).
TSMC revenue for September was approximately NT$152.69 billion,an increase of 19.7% YOY<blockquote>台积电9月营收约新台币1526.9亿元同比增长19.7%</blockquote>
Vendors who wanna sell their products at supermarkets have a pay a monthly rental for the shelving space. On top of that, the supermarkets also takes a small cut (commission) for each sale.Maybe it’s time Apple start explore how digital market place should be since regulars and legislations are still so outdated. Sad but if it can shuts those regulators up, it may be worth the effort. I doubt regulators are willing to break many traditional trades and established aged business models out there.